IMA Share Price Performance
US$7.96
-8.41 (-51.37%)
Price US$7.96
Share PriceUS$7.96
ImageneBio, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
IMA Community Narratives
There are no narratives available yet.
Recent IMA News & Updates
ImageneBio, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -3.03
- Gross Margin
- 100.00%
- Net Profit Margin
- -788.70%
- Debt/Equity Ratio
- -151.5%
ImageneBio, Inc. Competitors
Snowflake Analysis
About IMA
- Founded
- n/a
- Employees
- 9
- CEO
- WebsiteView website
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.S. Market Performance
- 7 Days: -2.8%
- 3 Months: 5.3%
- 1 Year: 13.4%
- Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.8%, driven by a decline of 2.5% in the Information Technology sector. In contrast to the last week, the market is actually up 13% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›